Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine

The duration of protection of the third (booster) dose of the BioNTech/Pfizer BNT162b2 mRNA Coronavirus Disease 2019 vaccine has been the subject of recent investigations, as global discussions around the necessity and effectiveness of a fourth dose are already underway. By conducting a retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Patalon, Tal, Saciuk, Yaki, Peretz, Asaf, Perez, Galit, Lurie, Yoav, Maor, Yasmin, Gazit, Sivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184525/
https://www.ncbi.nlm.nih.gov/pubmed/35680872
http://dx.doi.org/10.1038/s41467-022-30884-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184525/
https://www.ncbi.nlm.nih.gov/pubmed/35680872
http://dx.doi.org/10.1038/s41467-022-30884-6

Ejemplares similares